GlassScriptPhysician profile
Paul Kinberg
NPI 1285637876
$3,620.98
in general payments reported to CMS, 2019-2025
16 companies · $6.00 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,594 · 2020: $19.08 · 2021: $1,348 · 2022: $305 · 2023: $319 · 2024: $29.83 · 2025: $6.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $355.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $2,315.00 | 2019-2021 | |
| Organogenesis INC. | $418.96 | 2019-2023 | Puraply |
| Melinta Therapeutics, LLC | $274.38 | 2019-2021 | |
| Kerecis Limited | $180.01 | 2019-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Medtronic, INC. | $111.89 | 2022-2023 | Venaseal |
| Merck Sharp & Dohme LLC | $95.81 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $51.01 | 2023 | Jublia |
| Smith+Nephew, INC. | $43.12 | 2019-2023 | Bone Anchors With Arthroscopic Delivery System |
| Depuy Synthes Sales INC. | $29.83 | 2024 | Minibunion, N/A |
| Axogen | $22.64 | 2023 | Avance Nerve Graft |
| Averitas Pharma INC. | $17.93 | 2023 | Qutenza |
| Convatec INC. | $15.39 | 2019 | |
| Nuo Therapeutics | $14.63 | 2023 | |
| Nabriva Therapeutics, Plc | $12.80 | 2022 | |
| Wright Medical Technology, INC. | $11.58 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $6.00 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Kinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.